ARCHIVES

Waxman To Introduce Reauthorization Bill Next Month, Intends To Complete Action By Session End

This article is from The Cancer Letter archive.

Vol. 14 No. 30 | July 22, 1988

Download PDF Visit The Full Archive

Related Articles

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993